A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection.

A Phase I trial: dose escalation of melphalan in the "BEAM" regimen using amifostine cytoprotection. Biol Blood Marrow Transplant. 2011 Jul; 17(7):1033-42.

View in: PubMed

subject areas

Adult
Aged
Amifostine
Antineoplastic Combined Chemotherapy Protocols
Atrial Fibrillation
Carmustine
Combined Modality Therapy
Cytarabine
Cytoprotection
Dose-Response Relationship, Drug
Etoposide
Female
Humans
Lymphoma
Male
Maximum Tolerated Dose
Melphalan
Middle Aged
Mucositis
Pancytopenia
Peripheral Blood Stem Cell Transplantation
Postoperative Complications
Transplantation Conditioning
Transplantation, Autologous
Young Adult

authors with profiles

Michael A. Becker